284 related articles for article (PubMed ID: 3862924)
1. Characterization of differentiation-inducer-resistant HL-60 cells.
Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
[TBL] [Abstract][Full Text] [Related]
2. Surface membrane glycoproteins of wild-type and differentiation-inducer-resistant HL-60 cells.
Felsted RL; Gupta SK; Glover CJ; Gallagher RE
Blood; 1985 Sep; 66(3):606-13. PubMed ID: 4027382
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
[TBL] [Abstract][Full Text] [Related]
4. Hyposialylation of differentiation-inducer-resistant HL-60 cells.
Gallagher RE; Giangiulio DA; Chang CS; Glover CJ; Felsted RL
Blood; 1986 Dec; 68(6):1402-6. PubMed ID: 3779103
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation.
Grant S; Bhalla K; Weinstein B; Pestka S; Mileno MD; Fisher PB
Biochem Biophys Res Commun; 1985 Jul; 130(1):379-88. PubMed ID: 3861180
[TBL] [Abstract][Full Text] [Related]
6. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
7. The expression of the myc proto-oncogene in a dimethylsulfoxide resistant HL-60 cell line.
Grosso LE; Pitot HC
Cancer Lett; 1984 Feb; 22(1):55-63. PubMed ID: 6583000
[TBL] [Abstract][Full Text] [Related]
8. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
9. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes.
Mollinedo F; Gajate C; Tugores A; Flores I; Naranjo JR
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):137-44. PubMed ID: 8363564
[TBL] [Abstract][Full Text] [Related]
10. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine.
Yen A; Forbes ME
Cancer Res; 1990 Mar; 50(5):1411-20. PubMed ID: 2302706
[TBL] [Abstract][Full Text] [Related]
11. Enhanced mitogenic responsiveness to granulocyte-macrophage colony-stimulating factor in HL-60 promyelocytic leukemia cells upon induction of differentiation.
Schwartz EL; Maher AM
Cancer Res; 1988 May; 48(10):2683-7. PubMed ID: 2834046
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
[TBL] [Abstract][Full Text] [Related]
13. The effect of glutathione on HL-60 treated with dimethylsulfoxide, butyric acid or 12-O-tetradecanoylphorbol-13-acetate.
Zucker RM; Whittington KB; Decal DL
FEBS Lett; 1983 May; 155(1):107-12. PubMed ID: 6573264
[TBL] [Abstract][Full Text] [Related]
14. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells.
Zinzar S; Ohnuma T; Holland JF
Leuk Res; 1989; 13(1):23-30. PubMed ID: 2915572
[TBL] [Abstract][Full Text] [Related]
15. Comparative responsiveness of HL-60, HL-60R, and HL-60R+ (LRARSN) cells to retinoic acid, calcitriol, 9 cis-retinoic acid, and sodium butyrate.
Atkins KB; Troen BR
Blood; 1995 Oct; 86(7):2475-80. PubMed ID: 7670094
[TBL] [Abstract][Full Text] [Related]
16. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Herwig S; Su Q; Zhang W; Ma Y; Tempst P
Blood; 1996 Jan; 87(1):350-64. PubMed ID: 8547662
[TBL] [Abstract][Full Text] [Related]
17. Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatment.
Schwartsmann G; Pinedo HM; Leyva A
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):739-43. PubMed ID: 2443360
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.
Zylber-Katz E; Glazer RI
Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone modifies the functional responses of the granulocytic differentiating HL-60 cells.
Collado-Escobar D; Mollinedo F
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):553-9. PubMed ID: 7909661
[TBL] [Abstract][Full Text] [Related]
20. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
